The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...